Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001950912 | SCV002231559 | pathogenic | Fetal akinesia deformation sequence 1; Congenital myasthenic syndrome 11 | 2021-10-12 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Ile70Metfs*18) in the RAPSN gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in RAPSN are known to be pathogenic (PMID: 17686188). For these reasons, this variant has been classified as Pathogenic. This variant has not been reported in the literature in individuals affected with RAPSN-related conditions. This variant is present in population databases (rs760999895, ExAC 0.01%). |
Baylor Genetics | RCV003464308 | SCV004206113 | likely pathogenic | Fetal akinesia deformation sequence 2 | 2023-02-03 | criteria provided, single submitter | clinical testing |